1-34794334-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_002060.3(GJA4):c.121G>T(p.Gly41Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: not found (cov: 32)
Consequence
GJA4
NM_002060.3 missense
NM_002060.3 missense
Scores
7
10
2
Clinical Significance
Conservation
PhyloP100: 8.08
Genes affected
GJA4 (HGNC:4278): (gap junction protein alpha 4) This gene encodes a member of the connexin gene family. The encoded protein is a component of gap junctions, which are composed of arrays of intercellular channels that provide a route for the diffusion of low molecular weight materials from cell to cell. Mutations in this gene have been associated with atherosclerosis and a higher risk of myocardial infarction. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.926
PP5
Variant 1-34794334-G-T is Pathogenic according to our data. Variant chr1-34794334-G-T is described in ClinVar as [Pathogenic]. Clinvar id is 996750.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GJA4 | NM_002060.3 | c.121G>T | p.Gly41Cys | missense_variant | 2/2 | ENST00000342280.5 | NP_002051.2 | |
GJA4 | XM_005270750.3 | c.121G>T | p.Gly41Cys | missense_variant | 2/2 | XP_005270807.1 | ||
GJA4 | XM_017001043.3 | c.121G>T | p.Gly41Cys | missense_variant | 2/2 | XP_016856532.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GJA4 | ENST00000342280.5 | c.121G>T | p.Gly41Cys | missense_variant | 2/2 | 1 | NM_002060.3 | ENSP00000343676.4 | ||
SMIM12 | ENST00000426886.1 | n.207+61437C>A | intron_variant | 1 | ENSP00000429902.1 | |||||
GJA4 | ENST00000450137.1 | c.121G>T | p.Gly41Cys | missense_variant | 2/2 | 2 | ENSP00000409186.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Hepatic hemangioma Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | Yale Center for Mendelian Genomics, Yale University | Apr 08, 2021 | - - |
Pathogenic, no assertion criteria provided | research | Keith Choate Laboratory, Yale University | Dec 24, 2020 | The Gly41Cys variant in Cx37 was identified in hepatic hemangioma tissue from 12 unrelated patients. This variant was absent in normal liver tissue from the same respective individuals and was absent from 251,000 sequenced alleles in the gnomAD database. Further, in vitro functional studies demonstrate that the Gly41Cys variant leads to activation of SGK1, a serine/threonine kinase, via serine 78 phosphorylation. - |
Cutaneous venous malformation Pathogenic:1
Pathogenic, no assertion criteria provided | research | Keith Choate Laboratory, Yale University | Dec 24, 2020 | The Gly41Cys variant in Cx37 was identified in cutaneous venous malformations in 3 unrelated individuals. This variant was absent in normal tissue from the same respective individuals and was absent from 251,000 sequenced alleles in the gnomAD database. Further, in vitro functional studies demonstrate that the Gly41Cys variant leads to activation of SGK1, a serine/threonine kinase, via serine 78 phosphorylation. - |
Skin hemangioma Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | Yale Center for Mendelian Genomics, Yale University | Apr 08, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
M;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Pathogenic
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MutPred
Loss of disorder (P = 0.0261);Loss of disorder (P = 0.0261);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.